Biotherapy of cancer by targeting tp-3/p80

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2209767

Cytotoxic biotherapeutic agents effective for treating certain types of cancer in humans are provided which comprise the TP-3 murine monoclonal antibody chemically conjugated to pokeweed antiviral protein (PAP). The invention further provides a method which utilizes the disclosed cytotoxic biotherapeutic agents to systemically treat cancer patients. With slight modifications the method of the present invention should be generally applicable to preparation and use of other cytotoxic biotherapeutic agents using chemical or recombinant derivatives of the TP-3 or TP-1 antibodies or PAP toxin. The invention is applicable to cancer patients who express the p80 antigen recognized by the TP-1/TP-3 antibodies either on the surface of their tumor cells or on the tumor blood vessels.

L'invention concerne des agents biothérapeutiques cytotoxiques permettant de traiter certains types de cancer chez l'homme et comprenant l'anticorps monoclonal de murine de TP-3 conjugué chimiquement à la protéine antivirale du phytolaque (PAP). L'invention concerne, de plus, un procédé utilisant ces agents dans le traitement systémique de patients atteints du cancer. On devrait pouvoir appliquer ce procédé, avec de légères modifications, à la préparation et à l'utilisation d'autres agents biothérapeutiques cytotoxiques au moyen de dérivés chimiques ou recombinants des anticorps de TP-3 ou de TP-1 ou de la toxine de PAP. L'invention peut s'appliquer à des patients qui expriment l'antigène de p80 reconnu par les anticorps de TP-1/TP-3 soit sur la surface de leurs cellules cancéreuses, soit sur les vaisseaux sanguins de la tumeur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biotherapy of cancer by targeting tp-3/p80 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biotherapy of cancer by targeting tp-3/p80, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biotherapy of cancer by targeting tp-3/p80 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1955642

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.